Introduction
Multiple myeloma is an important hematological malignancy, 1 and is defined by the clonal proliferation of plasma cells. MM is responsible for ~1% of all cancers and ~2% of cancer deaths.
2 Some diagnostic criterion of multiple myeloma are monoclonal proteins, plasma cells with light chains secretion, and organ damages related to myeloma.
3 Some examples of end-organ damages in multiple myeloma are: hypercalcemia, renal failure, anemia, osteolytic lesions or osteoporosis, reduction of hematopoietic function and reduction of polyclonal immunoglobulin production.
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The bone marrow microenvironment known as niche and this microenvironment includes two components: cellular and non-cellular components. [8] [9] [10] [11] Stroma cells, endothelial cells, hematopoietic stem cells and pluripotent precursors, adipocytes, osteoblasts and osteoclasts constitute the cellular component. Mesenchymal stem cells (MSCs) are among these cells. These cells are multipotent and they can be differentiated into some mesodermal lineages such as osteocytes, adipocytes and chondrocytes. MSCs can be isolated from several tissues in cluding Umbilical Cord Blood, Bone Marrow, Placenta and Adipose tissue, Synovial fluid, Fetal pancreas, Lung, Liver, Amniotic fluid. 12 Several studies have demonstrated the supportive effects of MSCs for normal and malignant cells. 13, 14 The bone marrow stromal cells (BMSC) in MM cells microenvironment have supportive effects through direct or indirect contacts. When MM cells are localized in the bone marrow, via the interaction of cell surface adhesion molecules, they bind to the BMSCs and as a result, they trigger signaling pathways such as IL-6, SDF-1, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), insulin-like growth factor-1 (IGF-1), tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) and they are involved in tumor cells proliferation.
9, 15 One of the main signaling pathways in MM cells is the NF-κβ pathway. BM cells secret different factors, such as VEGF and IGF1, can indirectly activate the NF-κβ pathway in MM cells.
3,10 Also, in myeloma tumors, this signaling pathway supports cell survival, proliferation and resistance to anticancer drugs, however, the inhibition of NF-κβ is a vital option for anti-cancer therapies. 16 NF-κβ proteins consist of two great subfamilies: NF-κβ and 'Rel' molecules. 17 One of the most important proteins that plays a key role in this pathway is p65. This protein forms a dimer with p50, then they attach to Ikappa B alpha (IκBα). This event results in their translocation to the nucleus and gene transcription, so the NF-κβ transcription activity is dependend on p65 phosphorylation. 18 Previous studies have shown that this pathway can be very helpful in MM therapies. In this study, the effects of derived Umbilical Cord Blood-MSCs (UCB-MSCs) on the NF-κβ pathway activation in U266 cell lines were investigated. As well documented, Bone Marrow-MSCs derived from MM patients displayed multiple aberrant characteristics such as the production of certain cytokines, abnormal proliferative capacity, and distinctive genes expression. Moreover, in a variety of cancers, MSCs have been shown to exhibit tropism for migrating to tumor sites. Also, the vital role of MSCs in MM pathogenesis is now well established. 19 These findings led to the suggestion that activation of the NF-κβ pathway is essential for supporting roles of UCBMSCs in proliferation rate of U266. Therefore, this idea was examined using western blotting technique, in order to determine if p65 and phosphorylated p65 are activated through co-culturing that involves cell to cell interaction of UCB-MSCs with U266 cells, or not.
Materials and Methods

Cell Culture and Conditioned Medium (C.M) preparation
The U266 myeloma cell line was obtained from the Pasteur Institute of Iran. The cells were cultured and incubated in RPMI-1640 medium (Sigma-Aldrich, USA) with 10% fetal bovine serum (FBS, Gibco, UK), 100 U/ml penicillin, and 100 μg/ml streptomycin (Gibco, UK). U266 cells were cultured in a humidified incubator with 5% CO 2 at 37C. In all steps of the experiments, cell viability was checked by trypan-blue staining. It was found that cell viability exceeded 86% in all experiments. UCB-derived MSCs were purchased from the Pasteur Institute of Iran, then cultured and incubated in Low Glucose DMEM medium (Sigma-Aldrich, USA) with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin (Gibco, UK). In some steps of our experiments, we designed co-culture models by U266 cells and UCB-MSCs co-culturing. To this purpose, 2×10 3 UCB-MSCs were seeded in each well of 6 well plates and U266 cells (2×10 4 cell/well) were laid down on UCB-MSCs. DMEM was replaced with RPMI-1640 for co-culturing. For some tests, the C.M was required, so UCB-MSCs were incubated with RPMI-1640, without FBS, for 24 hrs. After incubation, C.M was collected and was used for tests.
MTT -assay
The proliferative effect of UCB-MSCs on U266 cells was determined by the MTT dye uptake method. In summary, the UCB-MSCs were cultured in 6 well plates and then U266 cells were added to UCB-MSCs with different concentrations (500, 1000, 2000, 5000, 10000 cell/well) and were incubated at 37°C for 48 hrs. Thereafter, 10 μL MTT (2.5 mg/mL in phosphatebuffered saline) was added to each well. After incubation, the U266 were collected and centrifuged. After centrifugation, the supernatant was removed and 200 μl RPMI-1640 with 10 μl 3-(4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide (MTT) solution (0.4 mg/ml) were added and incubated for 2.5 hrs. Then, Isopropanol/HCl (0.04M) was added and incubated in a humidified incubator with 5% CO 2 at 37C overnight. Finally, the optical density of solutions was measured by Picodrop (Picodrop, UK) at 580 and 650 nm.
Flow cytometry
In our experiments, we harvested U266 cells and washed them with PBS. In the next step, 20 μl of phycoerythrinconjugated anti-CD54 (Becton Dickinson, San Jose, CA, USA) was added to the cells for 30 min at 4C. In addition, forward and side scattering were used to distinguish live and apoptotic cells by flow cytometry (FACS Calibor, USA).
Western blot
At first, co-cultured U266 cells with UCB-MSCs were harvested by centrifugation and the resulting pellet was suspended in lysis buffer (10 Mm Tris-HCl, 1 mM EDTA, 0.1% (v/v) Triton-X100, PH 7.4) and sonicated at 4C. The supernatants were cleared by centrifugation and protein concentrations were analyzed by the Bradford assay. Total cell lysates for western blots were prepared after lysing of the cell pellets in radioimmunoprecipitation assay buffer. In this study, lysates were separated by 15% SDS-PAGE and were transferred to Immobile™-P nitrocellulose membranes. Equal amounts of proteins were resolved on 15% (w/v) acrylamide gels by SDS-PAGE and were transferred onto a nitrocellulose membrane. After the separation of proteins in the sample by gel electrophoresis, the transfer buffer (25 mM Tris, 192 mM glycine, pH 8.0, 20% methanol) was prepared. The proteins were transferred from the gel to a membrane. In the next step, the membrane was incubated for 1 h in blocking buffer (phosphatebuffered saline (PBS), 5% (w/v) nonfat dry milk or PBS, 0.1% (v/v) Tween-20 (PBS-T), 5% (w/v) nonfat dry milk), the membrane was immunoblotted with a 0.2-10 μg/ml primary antibody overnight at 4C. It was thereafter washed in PBS or PBS-T, then nitrocellulose sheets were incubated with a secondary antibody (67-1,000 ng/ml) for 3-4 hrs at room temperature with gentle agitation. The blot was washed to remove excess secondary antibody. More so, the blot was incubated using Pierce ECL Scientific kit that allowed the substrate to react with the blot for 2 min and this was carried out with gentle agitation in a tray. At the end, excess reagent was drained and Image blot which detects luminescent signal with film was utilized. The bands were detected on a cool camera BIO IMAGER film.
Real-time PCR (RT-PCR)
Total RNA containing genes were detected by RT-PCR. RNAs of U266 were isolated by QIAZOL (QIAGEN), thereafter, the quality of isolated RNA was checked by Pico drop (Picodrop,UK ). cDNA was produced by cDNA synthesis kit (Applied bio system) and RT-PCR was performed by RT-PCR kit (Applied bio system) on StepOne Plus instrument (Applied Biosystems) using standard protocols. The threshold cycle (Ct) value for each gene was normalized by the Ct number of housekeeping gene (β-actin). In this study, 8 genes with real-time PCR were analyzed (Primers shown in Table  1 ). The expression of 4 genes (CXCL1, CCL4, IL-6, and IL-8) was increased. Four of them (PECAM-1, JUNB, CCL2, CD44) were not changed. 
Genes
Forward Primer Reverse Primer IL-6 5`-AGACAGCCACTCACCTCTTCAG-3` 5`-TTCTGCCAGTGCCTCTTTGCTG-3`
Statistical analysis
Data are shown as means ± SD from three separate experiments. The data were evaluated using a GraphPad Prism v 5.00 (GraphPad Software, Inc., La Jolla, CA). Student's t-test (for single comparison) or two-way ANOVA (for multigroup comparisons) with Tukey post hoc test were used as appropriate. P < 0.05 was regarded as the statistical significance.
Results
UCB-MSCs supported proliferation rate of U266 cells
The UCB-MSCs (at the density of 2×10 3 cell/well) were cultured to 60% confluency in 6-wells plate. After that, U266 (2×10 4 cell/well) was laid down to UCBMSCs and cells were incubated for 48 hrs. After incubation, U266 were collected and MTT assay performed. The results were obtained from the MTT assay indicated that U266 proliferation was markedly higher in the co-culture with UCB-MSC, as compared with the control. In contrast, U266 proliferation cultured in C.M was unchanged, as compared with the control group (Figure 1) .
UCB-MSCs increased expression of CD54 on U266 cell line
CD54 expression is depend on NF-κβ signaling pathway activity. 20 In this regard, to determine the effect of UCBMSCs on CD54 expression, U266 cells were co-cultured with UCB-MSCs and incubated for 24 hrs. U266 cells in RPMI-1640 were referred to as the control group. After incubation, the cells were washed with PBS by centrifugation and mixed with 20 μl of phycoerythrinconjugated anti-CD54 (Becton Dickinson, San Jose, CA, USA). In addition, the forward and side scattering were used to distinguish live and dead cells by flow cytometry (FACS Calibor, USA). Sorting showed that (10 6 cells in 100 μl), CD54 expression increased in co-culture with UCB-MSCs (FACS Calibor, USA), whereas no increase was observed in the control group (Figure 2) . 
UCB-MSCs affected the NF-κβ signaling pathway in U266 cells
NF-κβ signaling pathway was analyzed by western blotting. Western blot performed to assess the protein levels of p65 and phosphorylated p65. Figure 3 shows the bands of p65 and phosphorylated p65 proteins. Phosphorylated p65 protein status is equivalent of NF-κβ activity, while p65 shows that NF-κβ is in inactive status. 21 According to our data, phosphorylated p65 increased markedly in presence of UCB-MSCs compare with the control group, while C.M did not show strong bands (Figure 3a) . Although, in the evaluation of p65 bands, no significant difference was observed between the control sample and the other conditions (Figure 3b) . 
Discussion
It has been shown that the bone marrow (BM) microenvironment influences the myeloma cells. 22 Also, myeloma cells have been connected to stromal cells and endothelial cells within the BM through direct cell-tocell contacts or indirectly, through soluble factors. [23] [24] [25] Importantly, in numerous researches, the survival and proliferation of malignant plasma cells rely on their interactions with nonmalignant stromal cells, in particular MSCs, in the BM microenvironment. On the other hand, previous studies have confirmed that MSCs produce soluble autocrine and paracrine factors such as IL-6, IGF-1, SDF-1α, and CXCL12, and have been shown to play an important role in the proliferation and survival of malignant cells. 26 Reagan et al. reported that malignant plasma cells induced IL-6 production in MSCs. As previously reported, IL-6 is one of the main growth and survival factors for MM cells, which can activates some signaling pathways; for instance, MAPK and the (PI-3K)/Akt signaling cascades mediate IL-6-induced MM cell growth and survival. [27] [28] [29] [30] [31] [32] Most recently, some studies have shown that NF-κβ activation in the regulation of IL-6 transcription is produced in the BMSCs after MM cell adhesion. Furthermore, stromal cells can induce some antiapoptotic pathways. 33 Several studies suggest that, the proliferation rate of MM cell lines in the presence of MSCs was promoted despite the control group. 34 Consist with this notion, the findings of the present study showed the supportive role of MSCs on U266 cells proliferation. CD54 (ICAM-1) is a surface antigen of plasma cells that is in close relation with NF-κβ signaling pathway and it makes difference between normal plasma cells and mature myeloma cells. 35 Our previous data showed that the activation of NF-κβ, increase the expression of CD54 in myeloma cells. Furthermore, P53 activates CD54 expression in an NF-κβ -independent manner. 36 In this study, flow cytometry data showed that the expression of CD54 on U266 surface increased after the cells were cocultured with MSCs. NF-κβ signaling cascade lead to a change in the expression of target genes, in which expression of CD54 was closely correlated with the activity of this pathway. Also, this study demonstrated that up-regulation of CD54 is parallel to NF-κβ activation in myeloma cells were co-cultured with MSC cells. Different studies have shown that human bone marrow derived mesenchymal stem cells regulate leukocyteendothelial interactions and activate the NF-κβ transcription factor. 37 In addition, several studies have shown that the NF-κβ pathway is vital to increase the survival and proliferation of normal plasma cells, MGUS and also obvious myeloma cells, can be inhibited by NF-κβ restriction drugs such as bortozomibe that target this pathway. Mitsiades et al. documented that the classical pathway of NF-κβ was activated in MM cell lines and NF-κβ plays an anti-apoptotic function in MM cell lines through the production of some proteins. 33 Moreover, NF-κβ controls a huge number of genes expressions, which play critical roles in the control of cell main functions such as cell survival, proliferation, apoptosis, adhesion and differentiation. The active NF-κβ transcription factor promotes the expression of over 150 target genes. [38] [39] [40] [41] The finding of the western blotting showed that phosphorylated p65 increased through the co-culturing of U266 cells with UCB-MSCs, although amount of p65 in U266 cells and U266 cells on UCB-MSC did not indicate significant change. Studies have documented that IKKB is a crucial component in the phosphorylation of p65 and may ignite the NF-κβ pathway activity, modulate the entry of phosphorylated p65 into the nucleus and activate gene transcription. 42, 43 Previous studies have demonstrated the presence of CXCL1 on MM cell lines and malignant plasma cells. 1,44 CCL2 was expressed by myeloma and BM stromal cells highly and western blot analysis confirmed that CCL2 promoted growth and survival signaling in macrophages in multiple myeloma patients via PI3K/Akt and ERK MAPK pathways activating. 45 CD44v10 and CD44v6 are effective in power selective homing of myeloma cells in the bone marrow. The level of IL-6 production seems dependend on expression of the CD44v9 isoforms in myeloma cells through cell-to cell contact, and some isoforms of CD44 were essential to induce growth factors such as IGF-1, FGF, HGF or HB-EGF. 46 
Conclusion
The findings of this study showed that stromal cells, such as MSCs, have supportive effects on proliferation rate of U266 cells. In addition, this study analyzed the molecular mechanisms of the supportive roles of MSCs on U266 cells through NF-κβ signaling pathway activity analyzing. In line with this, the up-regulation of the CD54 expression, which relates to NF-κβ signaling pathway activity, was observed and it could be a sign of NF-κβ activation in cells. On the other hand, increasing in amount of phosphorylated p65 protein confirmed NF-κβ activation. Furthermore, we demonstrated that MSCs changed the expression of CCL4, IL-6, IL-8, and CXCL1 in U266 cells, noticeably. Our result confirmed that MSCs paracrine activities in experiments and these observations provide evidences for important roles of MSCs, as a key component of the BM microenvironment, in facilitating the growth of malignant plasma cells in MM. Therefore, future studies are required to examine the effects of MSCs on the activation of NF-κβ signaling pathway in in vivo samples such as animals or multiple myeloma patients.
